Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism
Oncology Reports · 2026
DOI: 10.3892/or.2026.9184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2026. Verfasst von Xinhe Bai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China. Hauptthemen laut MEDLINE: Lung Neoplasms, Energy Metabolism, Indazoles, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Zitieren
APA
Bai, X., Yang, Y., Luo, Y., Jing, P., Hong, X., Zou, Y., Dai, Y., Yang, X., Zhou, M., Xiao, H., Huang, Y., Guo, S., & Fan, Q. (2026). Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism. Oncology Reports. https://doi.org/10.3892/or.2026.9184
Vancouver
Bai X, Yang Y, Luo Y, Jing P, Hong X, Zou Y, et al. Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism. Oncology Reports. 2026. doi:10.3892/or.2026.9184
BibTeX
@article{Bai2026,
author = {Bai, Xinhe and Yang, Yongfeng and Luo, Yuling and Jing, Pei and Hong, Xia and Zou, Yaqin and Dai, Yan and Yang, Xuping and Zhou, Meiling and Xiao, Han and Huang, Yilan and Guo, Shiwei and Fan, Qingze},
title = {Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9184}
}
EUVIMED